Kasuya H - Search Results

1

Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy.

Kasuya H, Nishiyama Y, Nomoto S, Goshima F, Takeda S, Watanabe I, Nomura N, Shikano T, Fujii T, Kanazumi N, Nakao A. Kasuya H, et al. Cancer Gene Ther. 2007 Jun;14(6):533-42. doi: 10.1038/sj.cgt.7701049. Epub 2007 Apr 6. Cancer Gene Ther. 2007. PMID: 17415379

2

Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer.

Kasuya H, Nishiyama Y, Nomoto S, Hosono J, Takeda S, Nakao A. Kasuya H, et al. J Surg Oncol. 1999 Nov;72(3):136-41. doi: 10.1002/(sici)1096-9098(199911)72:3<136::aid-jso5>3.0.co;2-3. J Surg Oncol. 1999. PMID: 10562359

3

Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer.

Nakao A, Oshima K, Takeda S, Kaneko T, Kanazumi N, Inoue S, Nomoto S, Kawase Y, Kasuya H. Nakao A, et al. Among authors: kasuya h. Hepatogastroenterology. 1999 Sep-Oct;46(29):2974-7. Hepatogastroenterology. 1999. PMID: 10576385

4

Combined effects of adeno-associated virus vector and a herpes simplex virus mutant as neoplastic therapy.

Kasuya H, Mizuno M, Yoshida J, Nishiyama Y, Nomoto S, Nakao A. Kasuya H, et al. J Surg Oncol. 2000 Jul;74(3):214-8. doi: 10.1002/1096-9098(200007)74:3<214::aid-jso12>3.0.co;2-y. J Surg Oncol. 2000. PMID: 10951421

5

Gene therapy for pancreatic cancer.

Kasuya H, Nomoto S, Kimata H, Harada A, Takeda S, Hayashi S, Nakao A. Kasuya H, et al. Hepatogastroenterology. 2001 Jul-Aug;48(40):957-61. Hepatogastroenterology. 2001. PMID: 11490848 Review.

6

Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.

Pawlik TM, Nakamura H, Mullen JT, Kasuya H, Yoon SS, Chandrasekhar S, Chiocca EA, Tanabe KK. Pawlik TM, et al. Among authors: kasuya h. Cancer. 2002 Sep 1;95(5):1171-81. doi: 10.1002/cncr.10776. Cancer. 2002. PMID: 12209705 Free article.

7

The potential of gene therapy in the treatment of pancreatic cancer.

Kasuya H, Nomoto S, Nakao A. Kasuya H, et al. Drugs Today (Barc). 2002 Jul;38(7):457-64. doi: 10.1358/dot.2002.38.7.820114. Drugs Today (Barc). 2002. PMID: 12582463 Review.

8

The potential of oncolytic virus therapy for pancreatic cancer.

Kasuya H, Takeda S, Nomoto S, Nakao A. Kasuya H, et al. Cancer Gene Ther. 2005 Sep;12(9):725-36. doi: 10.1038/sj.cgt.7700830. Cancer Gene Ther. 2005. PMID: 15818382 Review.

9

[Clinical application of replication competent mutant HSV in cancer therapy].

Kasuya H, Nakao A. Kasuya H, et al. Nihon Rinsho. 2006 Mar;64 Suppl 3:335-9. Nihon Rinsho. 2006. PMID: 16615494 Review. Japanese. No abstract available.

10

Oncolytic virus therapy--foreword.

Kasuya H, Takeda S, Shimoyama S, Shikano T, Nomura N, Kanazumi N, Nomoto S, Sugimoto H, Nakao A. Kasuya H, et al. Curr Cancer Drug Targets. 2007 Mar;7(2):123-5. doi: 10.2174/156800907780058826. Curr Cancer Drug Targets. 2007. PMID: 17346102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters